Eli Lilly at a Make-or-Break Zone as It Faces Pressure

Eli Lilly is entering a critical technical area after losing short-term momentum and slipping below its 20-day and 60-day moving averages. On the daily chart, the recent Market Structure Shift to the downside puts sellers in control for now, while price tests the $969 support zone near the 120-day moving average. That level matters because it is the last major daily trend support before the correction risks turning into a deeper unwind.

The primary path still leans cautious-to-bearish unless buyers can prove otherwise. A decisive daily close below $969 would confirm the range breakdown from the $1080–$1020 distribution zone and expose lower objectives toward $950, then $920, with the broader breakdown continuation target near $897. Momentum tools support that view, with MACD below zero and Squeeze Momentum showing rising bearish pressure. As long as price stays below $1045, rallies may continue to look like corrective bounces rather than a full trend reset.

The alternative scenario is a recovery that starts with a reclaim of resistance at $1045–$1046. A break-and-hold above that area would suggest the correction is losing force and could open the way back toward $1060, then a retest of the highs near $1100–$1118. On the weekly chart, the larger trend is still bullish, so this pullback remains structurally healthy unless price starts closing below the broader $960 area